Med Life (LTS:0RO5) 50-Day SMA: lei10.09 (As of Jul. 12, 2026)


LTS:0RO5 Med Life SA LTS:0RO5
75 GF Score
Price lei11.38
GF Value lei1.40
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Med Life 50-Day SMA?

Med Life LTS:0RO5 75 50-Day SMA is lei10.09 as of Jul. 12, 2026. GuruFocus rates LTS:0RO5 with a GF Score™ of 75/100 and a GF Value™ of lei1.40 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Moving averages are one of the core indicators in technical analysis. A Simple Moving Average (SMA) is simply the arithmetic average of stock price over a period. It is calculated by adding a selected range of prices, usually closing prices, and then dividing that figure by the number of time periods in that range.

The 50-Day SMA calculates the average price over 50 days. And the 20-Day SMA and 200-Day SMA calculates the average price over 20 days and 200 days separately.

As of today (2026-07-12), Med Life's 50-Day SMA is lei10.09. It's 20-Day SMA is lei11.38 and 200-Day SMA is lei8.51.


Med Life  (LTS:0RO5) 50-Day SMA Explanation

Simple Moving Average (SMA) is the arithmetic average of stock price over a period. The 20-Day SMA calculates the average price over 20 days. And the 50-Day SMA and 200-Day SMA calculates the average price over 50 days and 200 days separately. SMAs are often used to determine the price trend direction. A 200-Day SMA is usually a proxy for the long-term trend, while shorter periods indicate short-term trend.

SMA are commonly compared with stock price or different period SMAs to indicate a trading signal. Generally speaking, if the price goes above the SMA, or a short-term SMA crosses above a long-term SMA, an uptrend is expected, investors may want to go long or cover short. Conversely, if the price goes below the SMA, or the short-term SMA crosses below a long-term SMA, a downtrend is expected, investors may want to go short or exit long.

Two popular trading patterns that use SMA include the death cross and a golden cross. A death cross occurs when the 50-day SMA crosses below the 200-day SMA. This is considered a bearish signal, that further losses are in store. The golden cross is a bullish signal which occurs when a short-term SMA crosses above a long-term SMA.


Med Life 50-Day SMA Related Terms


LTS:0RO5 vs HCA, THC, DVA: 50-Day SMA Comparison

For the Medical Care Facilities subindustry, Med Life's 50-Day SMA, along with its competitors' market caps and 50-Day SMA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Med Life 50-Day SMA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Med Life's 50-Day SMA distribution charts can be found below:

* The bar in red indicates where Med Life's 50-Day SMA falls into.


LTS:0RO5
75GF Score
Med Life SA LTS:0RO5
50-Day SMA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Med Life  (LTS:0RO5) 50-Day SMA Calculation

The formula for calculating SMA is:

SMA=( P1 + P2 + ... + Pn ) / n

where:
Pn is the price of the stock at period n.
n is the total number of periods.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 50-Day SMA →
What does a 50-Day SMA of lei10.09 mean?
Med Life (LTS:0RO5) has a 50-Day SMA of lei10.09 as of Jul. 12, 2026. Simple Moving Average (SMA) is the arithmetic average of stock price over a period. View historical data on Med Life and its competitors.
Is Med Life's 50-Day SMA too high?
Med Life's current 50-Day SMA is lei10.09. Overall, Med Life has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Med Life's 50-Day SMA compare to HCA and THC?
Med Life's 50-Day SMA of lei10.09 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 50-Day SMA for a Healthcare Providers & Services company?
A good 50-Day SMA depends on the Healthcare Providers & Services industry context. However, 50-Day SMA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 50-Day SMA mean?
A high 50-Day SMA can signal that a stock is expensive relative to its fundamentals. Simple Moving Average (SMA) is the arithmetic average of stock price over a period. View historical data on Med Life and its competitors. Med Life's current 50-Day SMA is lei10.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med Life stock overvalued right now?
Based on GuruFocus' analysis, Med Life (LTS:0RO5) is currently considered Significantly Overvalued. The stock's GF Value™ is lei1.40, compared to a current price of lei11.38 — trading 712.5% above its estimated fair value. The current 50-Day SMA is lei10.09. Med Life's overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 50-Day SMA calculated?
50-Day SMA is calculated from a company's financial statements. For Med Life (LTS:0RO5), the current 50-Day SMA is lei10.09 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Med Life (LTS:0RO5) Overvalued in 2026?

Based on GuruFocus' analysis, Med Life stock appears to be overvalued. The current stock price of lei11.38 is trading 712.5% above its estimated GF Value™ of lei1.40. GuruFocus considers Med Life to be Significantly Overvalued.

Key valuation signals for LTS:0RO5:

  • 50-Day SMA: lei10.09
  • GF Value™: lei1.40 vs. price of lei11.38 (712.5% above fair value)
  • GF Score™: 75/100 with 6 warning signs

No single metric tells the full story. See the LTS:0RO5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Med Life Business Description

Other Exchanges M:RomaniaO0C:Germany
Address Calea Grivitei, No. 365, District 1, Bucharest, ROU
Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.
75GF Score

Get the complete analysis for LTS:0RO5

50-Day SMA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei11.38
Price
lei1.40
GF Value